Price T Rowe Associates Inc Standard Biotools Inc. Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 181,468 shares of LAB stock, worth $194,170. This represents 0.0% of its overall portfolio holdings.

Number of Shares

181,468

Previous 164,993 9.99%

Holding current value

$194,170

Previous $319,000 0.31%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.5 - $2.26 $24,712 - $37,233	16,475 Added 9.99%	181,468 $318,000
Q3 2024 Nov 14, 2024	SELL	$1.42 - $2.35 $71 - $117	-50 Reduced 0.03%	164,993 $319,000
Q2 2024 Aug 14, 2024	BUY	$1.65 - $2.92 $158,687 - $280,828	96,174 Added 139.65%	165,043 $293,000
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $78,669 - $116,951	42,069 Added 156.97%	68,869 $187,000
Q4 2023 Feb 14, 2024	SELL	$1.59 - $2.73 $18,444 - $31,668	-11,600 Reduced 30.21%	26,800 $60,000
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.56 $18,081 - $31,488	-12,300 Reduced 24.26%	38,400 $75,000
Q1 2023 May 15, 2023	SELL	$1.3 - $2.24 $44,460 - $76,608	-34,200 Reduced 40.28%	50,700 $99,000
Q4 2022 Feb 14, 2023	BUY	$0.93 - $1.52 $21,483 - $35,112	23,100 Added 37.38%	84,900 $99,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $2.06 $48,510 - $90,846	44,100 Added 249.15%	61,800 $68,000
Q2 2022 Aug 15, 2022	SELL	$1.6 - $3.99 $11,137 - $27,774	-6,961 Reduced 28.23%	17,700 $28,000
Q1 2022 May 16, 2022	BUY	$2.8 - $3.96 $5,320 - $7,524	1,900 Added 8.35%	24,661 $89,000
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $102,729 - $173,479	-28,300 Reduced 55.42%	22,761 $89,000
Q3 2021 Nov 15, 2021	SELL	$5.5 - $7.41 $42,795 - $57,657	-7,781 Reduced 13.22%	51,061 $336,000
Q2 2021 Aug 16, 2021	BUY	$4.35 - $6.35 $8,569 - $12,509	1,970 Added 3.46%	58,842 $362,000
Q1 2021 May 17, 2021	SELL	$3.94 - $7.09 $78,189 - $140,701	-19,845 Reduced 25.87%	56,872 $257,000
Q4 2020 Feb 16, 2021	BUY	$5.45 - $8.65 $418,107 - $663,602	76,717 New	76,717 $460,000

Others Institutions Holding LAB

# of Institutions

143

Shares Held

274M

Call Options Held

6.7K

Put Options Held

48.7K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $84.2M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Standard Biotools Inc. Transaction History